Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹270 Cr₹293 Cr₹241 Cr₹336 Cr₹279 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹270 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹270 Cr
Mar2025₹293 Cr
Mar2024₹241 Cr
Mar2023₹336 Cr
Mar2022₹279 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹270 Cr
-7.65
Mar2025 ₹293 Cr
21.25
Mar2024 ₹241 Cr
-28.28
Mar2023 ₹336 Cr
20.42
Mar2022 ₹279 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹129.4 Cr 4.9% 5.7% -42.9% Stock Analytics
ADANI ENTERPRISES ₹363,068.0 Cr -1.8% -1.3% 19.1% Stock Analytics
ADITYA INFOTECH ₹50,890.5 Cr -1.6% -6.6% 181.8% Stock Analytics
AEGIS LOGISTICS ₹42,915.0 Cr 4% -17.8% 60.8% Stock Analytics
PREMIER ENERGIES ₹40,714.9 Cr 1.3% -3% -13.1% Stock Analytics
REDINGTON ₹27,330.8 Cr 3.8% -13.1% 24.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

4.9%

5.7%

-42.9%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses